Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MKSI stock price vs AZPN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AZPN's multiple
Needs AZPN P/E.
Implied fair value · at MKSI's multiple
Needs EPS (TTM) is negative, MKSI P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MKSI FY 2025 (ended Dec 31, 2025) · AZPN FY 2024 (ended Jun 30, 2024). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
MKS INC. · implied price per share
Bear
$56.81
Base
$66.83
Bull
$76.85
ASPEN TECHNOLOGY, INC. · implied price per share
Bear
$53.78
Base
$63.27
Bull
$72.76
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.55x
0.02x
Net debt / EBITDA
Leverage against operating earnings
3.60x
0.08x
Cash and equivalents
Liquid reserves on the balance sheet
$419.00M
$236.97M
Total debt
Interest-bearing obligations outstanding
$4.20B
$273.65M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe MKSI can sustain its current profitability and growth trajectory despite 3.6x net debt/EBITDA, then holding rather than aggressively buying makes sense because the stock already trades well above the DCF range and at 68.1x earnings.
MKSI trades at a rich valuation relative to its own historical context, with a P/E of 68.1x and EV/EBITDA of 22.7x, while the DCF range of $104.46-$141.33 sits far below the current price of $297.45. The available data suggests the market is pricing in durable growth and quality, but the current quote is well above both intrinsic-value estimates and historical fair-value reference points.
Supporting Metrics
